Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P: Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 2010, 9: 1118–1127. 10.1016/S1474-4422(10)70223-4
Article
PubMed
Google Scholar
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007, 6: 734–746. 10.1016/S1474-4422(07)70178-3
Article
PubMed
Google Scholar
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH: The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011, 7: 263–269. 10.1016/j.jalz.2011.03.005
Article
PubMed
PubMed Central
Google Scholar
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011, 7: 270–279. 10.1016/j.jalz.2011.03.008
Article
PubMed
PubMed Central
Google Scholar
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosen E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttila T, Wallin A, Jonhagen ME, Minthon L, Winblad B, Blennow K: CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009, 302: 385–393. 10.1001/jama.2009.1064
Article
CAS
PubMed
Google Scholar
Wiltfang J, Esselmann H, Bibl M, Hull M, Hampel H, Kessler H, Frolich L, Schroder J, Peters O, Jessen F, Luckhaus C, Perneczky R, Jahn H, Fiszer M, Maler JM, Zimmermann R, Bruckmoser R, Kornhuber J, Lewczuk P: Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem 2007, 101: 1053–1059. 10.1111/j.1471-4159.2006.04404.x
Article
CAS
PubMed
Google Scholar
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM: CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer’s disease. J Neurosci 2010, 30: 2088–2101. 10.1523/JNEUROSCI.3785-09.2010
Article
CAS
PubMed
PubMed Central
Google Scholar
Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, Viitanen M, Parkkola R, Rinne JO: Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer’s disease. Ann Neurol 2008, 63: 112–118. 10.1002/ana.21212
Article
PubMed
Google Scholar
Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE: Amyloid imaging in Alzheimer’s disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. J Neurol Neurosurg Psychiatry 2012, 83: 923–926. 10.1136/jnnp-2012-302548
Article
PubMed
PubMed Central
Google Scholar
Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, Skovronsky DM, Reiman EM: Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol 2011, 68: 1404–1411. 10.1001/archneurol.2011.150
Article
PubMed
Google Scholar
Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasic JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ: In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med 2010, 51: 913–920. 10.2967/jnumed.109.069088
Article
CAS
PubMed
PubMed Central
Google Scholar
Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, Sabbagh MN, Sadowsky CH, Reiman PE, Zehntner SP, Skovronsky DM: Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 2011, 305: 275–283. 10.1001/jama.2010.2008
Article
CAS
PubMed
Google Scholar
Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST: Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain 2008, 131: 1630–1645. 10.1093/brain/awn016
Article
PubMed
PubMed Central
Google Scholar
Saint-Aubert L, Payoux P, Hannequin D, Barbeau EJ, Campion D, Delisle MB, Tafani M, Viallard G, Peran P, Puel M, Chollet F, Demonet JF, Pariente J: MR, 18F-FDG, and 18F-AV45 PET correlate with AD PSEN1 original phenotype. Alzheimer Dis Assoc Disord 2012, 27: 91–94.
Article
Google Scholar
Saint-Aubert L, Planton M, Hannequin D, Albucher JF, Delisle MB, Payoux P, Hitzel A, Viallard G, Peran P, Campion D, Laquerriere A, Barbeau EJ, Puel M, Raposo N, Chollet F, Pariente J: Amyloid imaging with AV45 ((18)F-florbetapir) in a cognitively normal AbetaPP duplication carrier. J Alzheimers Dis 2012, 28: 877–883.
PubMed
Google Scholar
Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, Pontecorvo MJ: Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology 2012, 79: 1636–1644. 10.1212/WNL.0b013e3182661f74
Article
CAS
PubMed
Google Scholar
Fleisher AS, Chen K, Liu X, Ayutyanont N, Roontiva A, Thiyyagura P, Protas H, Joshi AD, Sabbagh M, Sadowsky CH, Sperling RA, Clark CM, Mintun MA, Pontecorvo MJ, Coleman RE, Doraiswamy PM, Johnson KA, Carpenter AP, Skovronsky DM, Reiman EM: Apolipoprotein E epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging 2012, 34: 1–12.
Article
CAS
PubMed
Google Scholar
Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun MA, Pontecorvo MJ, Skovronsky DM: Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer’s disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement in press
La Joie R, Perrotin A, Barre L, Hommet C, Mezenge F, Ibazizene M, Camus V, Abbas A, Landeau B, Guilloteau D, de La Sayette V, Eustache F, Desgranges B, Chetelat G: Region-specific hierarchy between atrophy, hypometabolism, and beta-amyloid (Abeta) load in Alzheimer’s disease dementia. J Neurosci 2012, 32: 16265–16273. 10.1523/JNEUROSCI.2170-12.2012
Article
CAS
PubMed
Google Scholar
Rodrigue KM, Kennedy KM, Devous MD Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, Mathews D: Park DC: beta-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology 2012, 78: 387–395. 10.1212/WNL.0b013e318245d295
Article
CAS
PubMed
PubMed Central
Google Scholar
Sperling RA, Johnson KA, Doraiswamy PM, Reiman EM, Fleisher AS, Sabbagh MN, Sadowsky CH, Carpenter A, Davis MD, Lu M, Flitter M, Joshi AD, Clark CM, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ: Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging 2012, 34: 822–831.
Article
CAS
PubMed
PubMed Central
Google Scholar
Van-der-Linden M, Coyette F, Thomas-Antérion C, Sellal , Poitrenaud J, Gély-Nargeot , Linden JV, Kalafat M, Ergis , Adam S, Agniel A, Baisset-Mouly , Bardet , Desgranges B, Deweer : Neuropsychologie: L’évaluation des troubles de la mémoire: Présentation de quatre tests de mémoire épisodique (avec leur étalonnage). Marseille: Solal; 2004.
Google Scholar
Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992, 55: 967–972. 10.1136/jnnp.55.10.967
Article
CAS
PubMed
PubMed Central
Google Scholar
Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Scheltens P, Schmidt R: CT and MRI rating of white matter lesions. Cerebrovasc Dis 2002,13(Suppl 2):31–36.
Article
PubMed
Google Scholar
Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B: Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007, 69: 1859–1867. 10.1212/01.wnl.0000279336.36610.f7
Article
CAS
PubMed
Google Scholar
Wallon D, Rousseau S, Rovelet-Lecrux A, Quillard-Muraine M, Guyant-Marechal L, Martinaud O, Pariente J, Puel M, Rollin-Sillaire A, Pasquier F, Le Ber I, Sarazin M, Croisile B, Boutoleau-Bretonniere C, Thomas-Anterion C, Paquet C, Moreaud O, Gabelle A, Sellal F, Sauvee M, Laquerriere A, Duyckaerts C, Delisle MB, Streichenberger N, Lannes B, Frebourg T, Hannequin D, Campion D: The French series of autosomal dominant early onset Alzheimer’s disease cases: mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis 2012, 30: 847–856.
CAS
PubMed
Google Scholar
Strauss E, Sherman EMS, Spreen O: A Compendium of Neuropsychological Tests. Oxford: Oxford University Press; 2006.
Google Scholar
Barbeau E, Didic M, Tramoni E, Felician O, Joubert S, Sontheimer A, Ceccaldi M, Poncet M: Evaluation of visual recognition memory in MCI patients. Neurology 2004, 62: 1317–1322. 10.1212/01.WNL.0000120548.24298.DB
Article
CAS
PubMed
Google Scholar
Lacot E, Barbeau E, Thomas-Anterion C, Basaglia-Papas S, Pariente J, Puel M, Vaurtier S: TOP 12: how to interpret the responses as a measure of collective memory ability? Rev Neuropsychol 2011,4(3):273–283.
Article
Google Scholar
Mahieux-Laurent F, Fabre C, Galbrun E, Dubrulle A, Moroni C: [Validation of a brief screening scale evaluating praxic abilities for use in memory clinics. Evaluation in 419 controls, 127 mild cognitive impairment and 320 demented patients]. Rev Neurol (Paris) 2009, 165: 560–567. 10.1016/j.neurol.2008.11.016
Article
CAS
Google Scholar
Deloche G, Hannequin D: DO 80: Epreuve de Dénomination Orale d’images. Montreuil: ECPA; 1997.
Google Scholar
Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000, 55: 1621–1626. 10.1212/WNL.55.11.1621
Article
CAS
PubMed
Google Scholar
Lezak M, Howieson D, Loring D: Neuropsychological Assessment. 4th edition. Oxford: Oxford University Press; 2004.
Google Scholar
Avid Radiopharmaceuticals. http://www.avidrp.com/
Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M: Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15: 273–289. 10.1006/nimg.2001.0978
Article
CAS
PubMed
Google Scholar
Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, Yen TC, Kung MP: Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent–a pilot study. Nucl Med Biol 2010, 37: 497–508. 10.1016/j.nucmedbio.2010.02.003
Article
CAS
PubMed
Google Scholar
Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Arora A, Carpenter AP, Flitter ML, Joshi AD, Krautkramer MJ, Lu M, Mintun MA, Skovronsky DM: Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol 2012, 11: 669–678. 10.1016/S1474-4422(12)70142-4
Article
CAS
PubMed
Google Scholar
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B: Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 2004, 55: 306–319. 10.1002/ana.20009
Article
CAS
PubMed
Google Scholar
Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW: Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain 2011, 134: 1077–1088. 10.1093/brain/awr044
Article
PubMed
PubMed Central
Google Scholar
Villemagne VL, Pike KE, Chetelat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC: Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Ann Neurol 2011, 69: 181–192. 10.1002/ana.22248
Article
CAS
PubMed
PubMed Central
Google Scholar
Chetelat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O’Keefe GJ, Salvado O, Masters CL, Rowe CC: Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 2010, 67: 317–324.
CAS
PubMed
Google Scholar
Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC: Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease. Brain 2007, 130: 2837–2844. 10.1093/brain/awm238
Article
PubMed
Google Scholar
Resnick SM, Sojkova J, Zhou Y, An Y, Ye W, Holt DP, Dannals RF, Mathis CA, Klunk WE, Ferrucci L, Kraut MA, Wong DF: Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology 2010, 74: 807–815. 10.1212/WNL.0b013e3181d3e3e9
Article
CAS
PubMed
PubMed Central
Google Scholar
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL: Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol 2013, 12: 357–367. 10.1016/S1474-4422(13)70044-9
Article
CAS
PubMed
Google Scholar
Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ, Coart E, Morris JC, Holtzman DM: Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1–42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol 2011, 68: 1137–1144. 10.1001/archneurol.2011.105
Article
PubMed
PubMed Central
Google Scholar